David W. Grainger
Affiliated Society: Society for Biomaterials
Country of Residence: United States
Current Position: Professor and Chair, Department of Bioengineering, and University Distinguished Professor, Department of Pharmaceutical Chemistry, University of Utah, USA
David W. Grainger is the University Distinguished Professor and George S. and Dolores Dorí© Eccles Presidential Endowed Chair in Pharmaceutics and Pharmaceutical Chemistry, and Professor of Bioengineering at the University of Utah, USA. Grainger’s research focuses on improving drug delivery methods, implanted medical device and diagnostics performance, and nanomaterials toxicity. Grainger has published 190 research papers and 24 book chapters on biomaterials innovation in medicine and biotechnology, and novel surface and diagnostics chemistry. HIs research awards include a 2016 Fulbright Scholar Award (New Zealand), the 2013 Excellence in Surface Science Award (Surfaces in Biomaterials Foundation), the 2007 Clemson Award for Basic Research (Society for Biomaterials), and the 2005 American Pharmaceutical Research and Manufacturer’s Association’s award for Excellence in Pharmaceutics. Grainger has served as Chair of several of NIH’s prominent research review panels and now serves on the NIH NIBIB Council. He serves on the editorial boards for 6 major journals, is a handling editor for the journal, Biomaterials, for nearly two decades, and a special topics editor for Advanced Drug Delivery Reviews. He has organized 30 major scientific symposia. Grainger has also won numerous teaching awards and has provided over 365 invited lectures and workshop globally. He has actively translated biomedical intellectual property to industry, serving as both co-founder and scientific consultant to both Fortune 500 companies and start-up companies.
Areas of research interest:
Medical device innovation, Combination medical devices, Drug Delivery, Diagnostic devices and surface capture technologies, Surface modification, Perfluorinated polymers, Nanotoxoicology, 3-D cell culture and in vitro technologies
Biomaterials and Medical Products Commercialization